<antigenSupportingData>
<immunity>
</immunity>
<contraindications>
<vaccineGroup>
<contraindication>
<observationCode>080</observationCode>
<observationTitle>Adverse reaction to vaccine component</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had an adverse reaction to a vaccine component.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>123</observationCode>
<observationTitle>Severe allergic reaction after previous dose of ebola</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction after a previous dose of ebola vaccine.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
<contraindication>
<observationCode>124</observationCode>
<observationTitle>Severe allergic reaction to rice protein</observationTitle>
<contraindicationText>Do not vaccinate if the patient has had a severe allergic reaction to rice protein.</contraindicationText>
<contraindicationGuidance/>
<beginAge/>
<endAge/>
</contraindication>
</vaccineGroup>
</contraindications>
<series>
<seriesName>Ebola Risk 1-dose series</seriesName>
<targetDisease>Ebola</targetDisease>
<vaccineGroup>Ebola</vaccineGroup>
<seriesAdminGuidance/>
<seriesType>Risk</seriesType>
<equivalentSeriesGroups/>
<requiredGender/>
<selectSeries>
<defaultSeries>No</defaultSeries>
<productPath>No</productPath>
<seriesGroupName>Increased Risk</seriesGroupName>
<seriesGroup>1</seriesGroup>
<seriesPriority>A</seriesPriority>
<seriesPreference>1</seriesPreference>
<minAgeToStart>18 years</minAgeToStart>
<maxAgeToStart/>
</selectSeries>
<indication>
<observationCode>
<text>Ebola virus outbreak response</text>
<code>182</code>
</observationCode>
<description>Administer to persons responding to an outbreak of Ebola Virus Disease.</description>
<beginAge>18 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Health care personnel at federally designated Ebola treatement center in U.S.</text>
<code>183</code>
</observationCode>
<description>Administer to persons working as health care personnel at federally designated Ebola treatement centers in the Unied States</description>
<beginAge>18 years</beginAge>
<endAge/>
<guidance/>
</indication>
<indication>
<observationCode>
<text>Laboratorians or other staff at biosafety level 4 facilities in U.S.</text>
<code>184</code>
</observationCode>
<description>Administer to persons working as Laboratorians or other staff at biosafety level 4 facilities in U.S.</description>
<beginAge>18 years</beginAge>
<endAge/>
<guidance/>
</indication>
<seriesDose>
<doseNumber>Dose 1</doseNumber>
<age>
<absMinAge>18 years - 4 days</absMinAge>
<minAge>18 years</minAge>
<earliestRecAge>18 years</earliestRecAge>
<latestRecAge/>
<maxAge/>
<effectiveDate/>
<cessationDate/>
</age>
<interval/>
<allowableInterval/>
<preferableVaccine>
<vaccineType>Ebola Zaire vaccine, live</vaccineType>
<cvx>204</cvx>
<beginAge>18 years</beginAge>
<endAge/>
<tradeName/>
<mvx/>
<volume>1</volume>
<forecastVaccineType>N</forecastVaccineType>
</preferableVaccine>
<allowableVaccine>
<vaccineType>Ebola Zaire vaccine, live</vaccineType>
<cvx>204</cvx>
<beginAge>18 years - 4 days</beginAge>
<endAge/>
</allowableVaccine>
<inadvertentVaccine/>
<conditionalSkip/>
<recurringDose>No</recurringDose>
<seasonalRecommendation/>
</seriesDose>
</series>
</antigenSupportingData>
